Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | $8.73M | $13.89M | 87.24% | +$5.16M |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | $2.63M | $2.03M | 12.76% | -$593.4K |
| Kronos Bio, Inc. | 2,765,314 | 0 | -2,765,314 | $2.28M | $0 | — | -$2.28M |